Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
ANTM Stock Overview
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States.
Anthem Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$497.19 |
52 Week High | US$533.68 |
52 Week Low | US$355.43 |
Beta | 0.97 |
1 Month Change | -3.78% |
3 Month Change | 8.42% |
1 Year Change | 26.37% |
3 Year Change | 79.45% |
5 Year Change | 179.78% |
Change since IPO | 2,331.25% |
Recent News & Updates
Is It Too Late To Consider Buying Anthem, Inc. (NYSE:ANTM)?
Anthem, Inc. ( NYSE:ANTM ) saw a decent share price growth in the teens level on the NYSE over the last few months. As...
Does Anthem (NYSE:ANTM) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Shareholder Returns
ANTM | US Healthcare | US Market | |
---|---|---|---|
7D | 1.6% | 2.3% | 2.7% |
1Y | 26.4% | 5.6% | -8.1% |
Return vs Industry: ANTM exceeded the US Healthcare industry which returned 4.8% over the past year.
Return vs Market: ANTM exceeded the US Market which returned -10.8% over the past year.
Price Volatility
ANTM volatility | |
---|---|
ANTM Average Weekly Movement | 3.7% |
Healthcare Industry Average Movement | 10.2% |
Market Average Movement | 7.8% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ANTM is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ANTM's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1944 | 98,200 | Gail Boudreaux | https://www.antheminc.com |
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Anthem Fundamentals Summary
ANTM fundamental statistics | |
---|---|
Market Cap | US$119.00b |
Earnings (TTM) | US$6.24b |
Revenue (TTM) | US$144.35b |
19.2x
P/E Ratio0.8x
P/S RatioIs ANTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ANTM income statement (TTM) | |
---|---|
Revenue | US$144.35b |
Cost of Revenue | US$107.16b |
Gross Profit | US$37.19b |
Other Expenses | US$30.95b |
Earnings | US$6.24b |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 25.90 |
Gross Margin | 25.76% |
Net Profit Margin | 4.32% |
Debt/Equity Ratio | 64.5% |
How did ANTM perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield18%
Payout RatioDoes ANTM pay a reliable dividends?
See ANTM dividend history and benchmarksAnthem dividend dates | |
---|---|
Ex Dividend Date | Jun 09 2022 |
Dividend Pay Date | Jun 24 2022 |
Days until Ex dividend | 21 days |
Days until Dividend pay date | 36 days |
Does ANTM pay a reliable dividends?
See ANTM dividend history and benchmarksValuation
Is Anthem undervalued compared to its fair value and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
46.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANTM ($497.19) is trading below our estimate of fair value ($926.93)
Significantly Below Fair Value: ANTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANTM's PE Ratio (19.2x) is in line with the US Healthcare industry average.
PE vs Market: ANTM is poor value based on its PE Ratio (19.2x) compared to the US market (15.5x).
Price to Earnings Growth Ratio
PEG Ratio: ANTM is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: ANTM is overvalued based on its PB Ratio (3.3x) compared to the US Healthcare industry average (2.5x).
Future Growth
How is Anthem forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
10.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANTM's forecast earnings growth (10.3% per year) is above the savings rate (1.9%).
Earnings vs Market: ANTM's earnings (10.3% per year) are forecast to grow slower than the US market (12.5% per year).
High Growth Earnings: ANTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANTM's revenue (6.8% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: ANTM's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANTM's Return on Equity is forecast to be low in 3 years time (18.6%).
Past Performance
How has Anthem performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
11.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANTM has high quality earnings.
Growing Profit Margin: ANTM's current net profit margins (4.3%) are higher than last year (3.8%).
Past Earnings Growth Analysis
Earnings Trend: ANTM's earnings have grown by 11.9% per year over the past 5 years.
Accelerating Growth: ANTM's earnings growth over the past year (32.5%) exceeds its 5-year average (11.9% per year).
Earnings vs Industry: ANTM earnings growth over the past year (32.5%) exceeded the Healthcare industry 9.6%.
Return on Equity
High ROE: ANTM's Return on Equity (17.3%) is considered low.
Financial Health
How is Anthem's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: ANTM's short term assets ($53.9B) exceed its short term liabilities ($39.7B).
Long Term Liabilities: ANTM's short term assets ($53.9B) exceed its long term liabilities ($24.7B).
Debt to Equity History and Analysis
Debt Level: ANTM has more cash than its total debt.
Reducing Debt: ANTM's debt to equity ratio has reduced from 70.4% to 64.5% over the past 5 years.
Debt Coverage: ANTM's debt is well covered by operating cash flow (36.1%).
Interest Coverage: ANTM's interest payments on its debt are well covered by EBIT (11.2x coverage).
Balance Sheet
Dividend
What is Anthem current dividend yield, its reliability and sustainability?
Dividend Score
4/6Dividend Score 4/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
1.03%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ANTM's dividend (1.03%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: ANTM's dividend (1.03%) is low compared to the top 25% of dividend payers in the US market (4.06%).
Stability and Growth of Payments
Stable Dividend: ANTM's dividends per share have been stable in the past 10 years.
Growing Dividend: ANTM's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (18.2%), ANTM's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (17%), ANTM's dividend payments are well covered by cash flows.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.9yrs
Average management tenure
CEO
Gail Boudreaux (60 yo)
4.5yrs
Tenure
US$19,348,241
Compensation
Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Anthem, Inc. since November 11, 2...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD19.35M) is above average for companies of similar size in the US market ($USD13.27M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: ANTM's management team is seasoned and experienced (5.9 years average tenure).
Board Members
Experienced Board: ANTM's board of directors are considered experienced (8.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANTM insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Anthem, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Anthem, Inc.
- Ticker: ANTM
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Implied Market Cap: US$118.997b
- Shares outstanding: 241.08m
- Website: https://www.antheminc.com
Number of Employees
Location
- Anthem, Inc.
- 220 Virginia Avenue
- Indianapolis
- Indiana
- 46204
- United States
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/17 00:00 |
End of Day Share Price | 2022/05/17 00:00 |
Earnings | 2022/03/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.